中华肿瘤杂志
中華腫瘤雜誌
중화종류잡지
CHINESE JOURNAL OF ONCOLOGY
2009年
1期
72-74
,共3页
方仪%高纪东%田艳涛%谢玉权%郑闪
方儀%高紀東%田豔濤%謝玉權%鄭閃
방의%고기동%전염도%사옥권%정섬
乳腺肿瘤%分叶状肿瘤%预后
乳腺腫瘤%分葉狀腫瘤%預後
유선종류%분협상종류%예후
Breast neoplasms%Phyllodes tumor,recurrence%Prognosis
目的 探讨乳腺叶状肿瘤复发的治疗方法以及预后.方法 回顾分析1972年3月至2006年6月收治的26例乳腺叶状肿瘤复发患者的临床资料.结果 26例患者的中位生存时间为96个月.原发肿瘤≥5 cm者10例,其中6例出现局部复发,4例死亡;<5 cm者16例,其中5例出现局部复发,3例死亡.复发肿瘤≥5 cm者14例,其中5例出现局部复发,3例死亡;<5 cm者12例,其中6例出现局部复发,4例死亡.原发肿瘤和复发肿瘤的大小对肿瘤再次复发(P=0.094,P=0.383)和预后(P=0.142,P=0.486)影响不显著.良性肿瘤组12例患者中,3例出现局部复发,2例死亡;恶性肿瘤组14例患者中,8例小现局部复发,5例死亡.乳腺叶状肿瘤的良恶性与肿瘤再次复发(P=0.046)和预后(P=0.028)存存相关性.结论 乳腺叶状肿瘤的恶性程度对肿瘤再次局部复发和患者预后有显著影响,而肿瘤大小与再次局部复发和预后无关.乳腺叶状肿瘤复发后的补救手术十分重要,手术必须保证一定的安全范围;多次局部复发患者的于术治疗效果较好.
目的 探討乳腺葉狀腫瘤複髮的治療方法以及預後.方法 迴顧分析1972年3月至2006年6月收治的26例乳腺葉狀腫瘤複髮患者的臨床資料.結果 26例患者的中位生存時間為96箇月.原髮腫瘤≥5 cm者10例,其中6例齣現跼部複髮,4例死亡;<5 cm者16例,其中5例齣現跼部複髮,3例死亡.複髮腫瘤≥5 cm者14例,其中5例齣現跼部複髮,3例死亡;<5 cm者12例,其中6例齣現跼部複髮,4例死亡.原髮腫瘤和複髮腫瘤的大小對腫瘤再次複髮(P=0.094,P=0.383)和預後(P=0.142,P=0.486)影響不顯著.良性腫瘤組12例患者中,3例齣現跼部複髮,2例死亡;噁性腫瘤組14例患者中,8例小現跼部複髮,5例死亡.乳腺葉狀腫瘤的良噁性與腫瘤再次複髮(P=0.046)和預後(P=0.028)存存相關性.結論 乳腺葉狀腫瘤的噁性程度對腫瘤再次跼部複髮和患者預後有顯著影響,而腫瘤大小與再次跼部複髮和預後無關.乳腺葉狀腫瘤複髮後的補救手術十分重要,手術必鬚保證一定的安全範圍;多次跼部複髮患者的于術治療效果較好.
목적 탐토유선협상종류복발적치료방법이급예후.방법 회고분석1972년3월지2006년6월수치적26례유선협상종류복발환자적림상자료.결과 26례환자적중위생존시간위96개월.원발종류≥5 cm자10례,기중6례출현국부복발,4례사망;<5 cm자16례,기중5례출현국부복발,3례사망.복발종류≥5 cm자14례,기중5례출현국부복발,3례사망;<5 cm자12례,기중6례출현국부복발,4례사망.원발종류화복발종류적대소대종류재차복발(P=0.094,P=0.383)화예후(P=0.142,P=0.486)영향불현저.량성종류조12례환자중,3례출현국부복발,2례사망;악성종류조14례환자중,8례소현국부복발,5례사망.유선협상종류적량악성여종류재차복발(P=0.046)화예후(P=0.028)존존상관성.결론 유선협상종류적악성정도대종류재차국부복발화환자예후유현저영향,이종류대소여재차국부복발화예후무관.유선협상종류복발후적보구수술십분중요,수술필수보증일정적안전범위;다차국부복발환자적우술치료효과교호.
Objective To explore the methods of diagnosis, treatment and prognosis for patients with recurrent breast phyllodes tumor. Methods Clinicopathological data of 26 patients with pathologically proven recurrent phyllodes tumors treated from March 1972 to June 2006 were retrospectively analyzed. Results The mean age of the 26 cases was 45 years, and the median follow-up duration was 83 months. The mean overall survival time of this series was 96 months. The primary breast phyllodes tumor was ≥ 5 cm in 10 cases with a recurrence rate of 60.0% (6/10 cases) ; <5 cm in 16 cases with a recurrence rate of 31.3% 5/16 cases). After surgical removal of the breast primary tumor, the recurrent tumor was ≥5 cm in 14 cases with a re-recurrence rate of 35.7% (5/14 cases) ; <5 cm was in 12 cases with are-recurrence rate of 50.0% (6/12 cases). There was no statistically significant relationship between the (primary and reccurent) tumor size and recurrence rate (P=0.094, P=0.383) or prognosis (P=0.142, P=0.486). The benign or malignant nature of the breast phyllodes tumor was significantly correlated with the rate of local re-recurrence (P=0.046) and prognosis (P=0.028). Conclusion The benign or malignant nature of the breast phyllodes tumor is significantly correlated with the local re-recurrence and prognosis, while the size of the primary breast phyllodes tumor has no significant effect on either re-recrruence or prognosis. The first rescue operation is most important in the treatment of recurrent breast phyllodes tumor. The resection margin should be wide enough. Active surgical treatment can still effectively save the life of the patients with a local re-recurrent tumor.